Siga Technologies (SIGA) Current Assets (2010 - 2025)
Siga Technologies' (SIGA) quarterly Current Assets came in at $212.9 million in Q4 2025, down 7.87% on a YoY basis from $231.0 million in Q4 2024, and down 6.54% quarter-over-quarter from $227.7 million in Q3 2025.
Analysis
Siga Technologies (SIGA) Current Assets (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Current Assets for 16 consecutive years, with $212.9 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Current Assets fell 7.87% year-over-year to $212.9 million; the trailing twelve-month figure through Dec 2025 stood at $212.9 million (down 7.87% YoY), and the FY2025 full-year result was $212.9 million, down 7.87% from the prior year.
- Current Assets eased to $212.9 million in Q4 2025 per SIGA's latest filing, from $227.7 million in the prior quarter.
- Across five years, Current Assets topped out at $239.0 million in Q4 2023 and bottomed at $127.1 million in Q2 2021.
- Historically, Current Assets has averaged $186.1 million across 5 years, with a median of $183.2 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Current Assets surged 52.71% in 2022, then fell 25.87% in 2023.
- Over 5 years, Current Assets stood at $208.8 million in 2021, then declined by 11.0% to $185.8 million in 2022, then gained by 28.64% to $239.0 million in 2023, then retreated by 3.32% to $231.0 million in 2024, then dropped by 7.87% to $212.9 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $212.9 million, $227.7 million, and $229.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 41.36 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 36.64 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 4.03 Bn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 6.03 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 3.48 Bn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | 212.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 212.86 Mn |
| Sep 30, 2025 | 227.75 Mn |
| Jun 30, 2025 | 229.20 Mn |
| Mar 31, 2025 | 233.62 Mn |
| Dec 31, 2024 | 231.04 Mn |
| Sep 30, 2024 | 180.69 Mn |
| Jun 30, 2024 | 176.48 Mn |
| Mar 31, 2024 | 227.89 Mn |
| Dec 31, 2023 | 238.99 Mn |
| Sep 30, 2023 | 145.97 Mn |
| Jun 30, 2023 | 134.30 Mn |
| Mar 31, 2023 | 172.53 Mn |
| Dec 31, 2022 | 185.79 Mn |
| Sep 30, 2022 | 196.90 Mn |
| Jun 30, 2022 | 153.64 Mn |
| Mar 31, 2022 | 177.11 Mn |
| Dec 31, 2021 | 208.75 Mn |
| Sep 30, 2021 | 128.94 Mn |
| Jun 30, 2021 | 127.07 Mn |
| Mar 31, 2021 | 132.89 Mn |